Evidence map›Paper›PMID 42811018›Full record

ArticleNature communications2026

A pre-train and fine-tune framework for adaptive boosting of pre-trained polygenic risk scores.

Jie Hu, Raelynn Chen, Maxwell Salvatore, Olivia Wu, Okan Bilge Ozdemir, Yiwen Lu, Shawn N Murphy, Elizabeth W Karlson, Atlas Khan, Krzysztof Kiryluk and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Jie Hu *Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-3060-1574
Raelynn Chen *Department of Computational Biomedicine, Cedars-Sinai Health Sciences University, Los Angeles, CA, USA.ORCID 0009-0006-5737-8292
Maxwell SalvatoreDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-3659-1514
Olivia WuDepartment of Computational Biomedicine, Cedars-Sinai Health Sciences University, Los Angeles, CA, USA.ORCID 0009-0001-7204-2416
Okan Bilge OzdemirDepartment of Computational Biomedicine, Cedars-Sinai Health Sciences University, Los Angeles, CA, USA.ORCID 0000-0002-2829-3672
Yiwen LuDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-8610-2416
Shawn N MurphyMass General Brigham, Boston, MA, USA.
Elizabeth W KarlsonDivision of Rheumatology, Immunity and Inflammation, Brigham and Women's Hospital, Boston, MA, USA.
Atlas KhanColumbia University Medical Center, Columbia University, New York, NY, USA.ORCID 0000-0002-6651-2725
Krzysztof KirylukDivision of Nephrology, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.ORCID 0000-0002-5047-6715
Iftikhar J KulloDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-6524-3471
Johanna L SmithDepartment of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-5861-0413
Eimear E KennyDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0001-9198-759X
Yuan LuoDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0003-0195-7456
Zaldy S TanDepartment of Neurology & Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
William G La CavaDepartment of Pediatrics, Havard Medical School, Boston, MA, USA.
Marylyn D RitchieDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0002-1208-1720
Yong ChenDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA, USA. ychen123@pennmedicine.upenn.edu.ORCID 0000-0003-0835-0788
Ruowang LiDepartment of Computational Biomedicine, Cedars-Sinai Health Sciences University, Los Angeles, CA, USA. Ruowang.Li@csmc.edu.ORCID 0000-0002-7910-4253

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polygenic risk scores are widely used for predicting genetic risk across complex diseases and traits, and several pre-trained models have been developed. Few approaches leverage these pre-trained polygenic risk scores to further refine predictive performance. Here, we present Adaptive Boosting of pre-trained Polygenic Risk Socres, a fine-tuning framework that refines pre-trained polygenic risk score models through adaptive variable selection and model boosting to identify additional predictive signals that may not be fully captured by the original models. Simulations show that our framework can identify signals orthogonal to pre-trained polygenic risk scores while controlling false discovery rates. Using UK Biobank data, we fine-tune pre-trained polygenic risk scores for binary diseases and continuous traits, and validate the results across three independent datasets: All of Us, eMERGE, and Penn Medicine Biobank. Real data analyses show that Adaptive Boosting of pre-trained Polygenic Risk Scores achieves statistically significant improvements in several scenarios while maintaining competitive performance in others.

Indexed as

Genetic Predisposition to DiseaseMultifactorial InheritanceBoosting Machine Learning AlgorithmsComputer SimulationGenetic Risk ScoreGenome-Wide Association StudyHumansModels, GeneticPrediction AlgorithmsUK Biobank

Identifiers

PMID42811018
PMCPMC13623977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.